Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction by Chirinos, Julio A et al.
European Journal of Heart Failure (2017) 19, 1507–1515 RESEARCH ARTICLE
doi:10.1002/ejhf.885
Effects of organic and inorganic nitrate on
aortic and carotid haemodynamics in heart
failure with preserved ejection fraction
Julio A. Chirinos1*†, Francisco Londono-Hoyos1,2†, Payman Zamani1†,
Melissa Beraun1, Philip Haines3, Izzah Vasim1,4, Swapna Varakantam1,4,
Timothy S. Phan1, Thomas P. Cappola1, Kenneth B. Margulies1,
Raymond R. Townsend1, and Patrick Segers2
1University of Pennsylvania Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; 2Institute of Biomedical Technology, Ghent University,
Ghent, Belgium; 3Warren Alpert Medical School of Brown University, Providence, RI, USA; and 4Philadelphia VA Medical Center, Philadelphia, PA, USA
Received 28 October 2016; revised 4 April 2017; accepted 10 April 2017 ; online publish-ahead-of-print 25 May 2017
Aims To assess the haemodynamic effects of organic vs. inorganic nitrate administration among patients with heart failure
with preserved ejection fraction (HFpEF).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Methods
and results
We assessed carotid and aortic pressure–flow relations non-invasively before and after the administration of 0.4mg of
sublingual nitroglycerin (n= 26), and in a separate sub-study, in response to 12.9 mmoL of inorganic nitrate (n=16).
Nitroglycerin did not consistently reduce wave reflections arriving at the proximal aorta (change in real part of
reflection coefficient, 1st harmonic:−0.09; P= 0.01; 2nd harmonic:−0.045, P= 0.16; 3rd harmonic:+0.087; P= 0.05),
but produced profound vasodilatation in the carotid territory, with a significant reduction in systolic blood pressure
(133.6 vs. 120.5mmHg; P= 0.011) and a marked reduction in carotid bed vascular resistance (19 580 vs. 13 078
dynes ⋅ s/cm5; P= 0.001) and carotid characteristic impedance (3440 vs. 1923 dynes ⋅ s/cm5; P= 0.002). Inorganic
nitrate, in contrast, consistently reduced wave reflections across the first three harmonics (change in real part of
reflection coefficient, 1st harmonic: −0.12; P= 0.03; 2nd harmonic: −0.11, P= 0.01; 3rd harmonic: −0.087; P= 0.09)
and did not reduce blood pressure, carotid bed vascular resistance, or carotid characteristic impedance (P=NS).
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Conclusions Nitroglycerin produces marked vasodilatation in the carotid circulation, with a pronounced reduction in blood
pressure and inconsistent effects on central wave reflections. Inorganic nitrate, in contrast, produces consistent
reductions in wave reflections, and unlike nitroglycerin, it does so without significant hypotension or cerebrovascular
dilatation. These haemodynamic differences may underlie the different effects on exercise capacity and side effect
profile of inorganic vs. organic nitrate in HFpEF.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Keywords Arterial load • Cerebrovascular input impedance • Heart failure with preserved ejection fraction •
Inorganic nitrate • Organic nitrate
Introduction
Heart failure (HF) affects ∼2% of the western population and is
the most common cause of hospitalization in adults >65 years
of age. Approximately half of patients with HF have a preserved
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. left ventricular (LV) ejection fraction (HFpEF). Multiple effective
pharmacological therapies that result in substantial clinical benefit
in HF with reduced ejection fraction are available. In contrast,
there are currently no proven effective pharmacological therapies
to improve outcomes in HFpEF.
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Pulsatile arterial load exerts important effects on LV function
and remodelling. In particular, wave reflections originating at the
periphery and conducted back to the heart, have been shown
to cause LV diastolic dysfunction, hypertrophy and fibrosis in
experimental models, a concept supported by an increasing body
of human studies.1–6 Acute administration of organic nitrates has
been shown to reduce wave reflections arriving at the central
aorta in hypertensive or healthy subjects in some, but not all
studies.7–11 The effects of organic nitrates on pulsatile arterial
haemodynamics have not been well characterized in HFpEF. In
recent trials in patients with HFpEF,12,13 organic nitrates have been
poorly tolerated; important side effects of organic nitrate therapy
included hypotension and headaches, suggesting adverse effects
on the cerebrovascular territory.
In contrast to the unfavourable effects of organic nitrates in
HFpEF, recent randomized controlled trials have demonstrated
that inorganic nitrate, administered as a single dose14 or after one
week of sustained administration,15 improves exercise capacity in
patients with HFpEF. Inorganic nitrate undergoes a two-step reduc-
tion to nitric oxide (NO) via the nitrate–nitrite–NO pathway.16,17
The conversion of nitrite to NO occurs in conditions of hypoxia
and acidosis, but a recent report indicates that it also occurs via
paradoxical normoxic activation in conduit arteries,18 indicating
potential effects on pulsatile arterial haemodynamic function and
arterial wave reflections. Furthermore, in contrast to the frequent
occurrence of headache with organic nitrate, the administration of
inorganic nitrate has not been associated with headaches or other
side effects in two recent trials in this population.14,15
We aimed to assess the effect of organic and inorganic nitrate
in HFpEF on (i) wave reflections arriving at the central aorta,
and (ii) carotid arterial haemodynamics (i.e. to characterize
cerebrovascular effects).
Methods
We performed two sub-studies. In the first sub-study, we assessed aor-
tic and carotid haemodynamics at baseline and after the administration
of 0.4mg of sublingual nitroglycerin (NTG). In the second sub-study,
we analysed aortic and carotid pressure–flow data from our previ-
ous randomized controlled trial of inorganic nitrate administration in
HFpEF.14 Protocols were approved by the University of Pennsylvania
and Philadelphia VA Medical Center Institutional Review Boards, as
appropriate. All subjects provided written informed consent.
Study population
For sub-study 1, we included subjects with HFpEF who met the
following criteria: (i) symptomatic HF with a LV ejection fraction
>50%; (ii) at least one of the following within one year prior to
consent: hospitalization for decompensated HF, acute treatment
for HF with intravenous diuretics or haemofiltration, chronic treat-
ment with a loop diuretic for control of HF symptoms, or chronic
diastolic dysfunction evidenced by left atrial enlargement (left atrial
volume index >34mL/m2), or Doppler signs of increased left atrial
pressure, as defined by the European Society of Cardiovascular
Imaging/American Society of Echocardiography;19 (iii) stable medical
therapy. Key exclusion criteria were: (i) clinically significant valve ..
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.. disease (more than mild aortic/mitral stenosis or more than moderate
aortic/mitral regurgitation); (ii) atrial fibrillation/flutter; (iii) current
nitrate therapy; (iv) significant ischaemia on stress testing within the
past year that was not revascularized; (v) other clinically important
causes of dyspnoea; (vi) hypertrophic, infiltrative, or inflammatory
cardiomyopathy; (vii) pericardial disease; (viii) primary pulmonary arte-
riopathy; (ix) blood pressure <110/40mmHg or >180/100mmHg; (x)
resting heart rate >100 b.p.m.; (xi) LV ejection fraction <50% in the
past; (xii) adverse reactions to organic nitrates or phosphodiesterase
inhibitor use; (xiii) severe renal dysfunction (glomerular filtration rate
<30mL/min/1.73m2), or liver disease. In sub-study 2, we utilized very
similar inclusion/exclusion criteria, as previously described.14
Study protocol
Sub-study 1
Twenty-six subjects participated in this sub-study. After >10min of
rest in the supine position, blood pressure was taken in the right
arm with a validated oscillometric device (Omron HEM-705CP, Omron
Corporation, Kyoto, Japan). Carotid pressure (Figure 1) was recorded
via applanation tonometry, using a SphygmoCor-CPV System (AtCor
Medical, Itasca, IL, USA) equipped with a high-fidelity Millar tonometer
(Millar Instruments, Houston, TX, USA).
Pulsed-wave Doppler measurements of flow velocities in the LV out-
flow tract (Figure 1) were performed using a GE-e9 ultrasound machine
(GE Healthcare, Fairfield, CT, USA), with the Doppler sample immedi-
ately proximal to the aortic valve leaflets within the centerline of the
LV outflow tract. We computed LV outflow tract cross-sectional area
from its radius measured in the parasternal long-axis view (area=𝜋r2).
Carotid diameters and blood velocities were also acquired, using a
vascular linear probe. Carotid flow was computed as flow velocity
multiplied by lumen cross-sectional area (area=𝜋r2). After baseline
measurements were obtained, a single dose (0.4mg) of NTG was
administered sublingually, and measurements were repeated starting
2min after administration. Comparisons were made between the mea-
surements obtained pre- vs. post-NTG administration.
Sub-study 2
Seventeen subjects participated in a randomized, double-blind,
cross-over study of a single dose of inorganic nitrate given as concen-
trated nitrate-rich beetroot juice (NO3
−, BEET-IT Sport, James White
Drinks Ltd, Ipswich, UK) containing 12.9 mmoL NO3
− in 140mL, vs.
an otherwise identical nitrate-depleted placebo juice (James White
Drinks, Ltd). The interventions were separated by a wash-out period
of at least 5 days. We measured aortic and carotid heamodynamics
using identical methods as in sub-study 1, ∼2.5 h after juice ingestion.
Comparisons were made between measurements obtained after
administration of nitrate-rich vs. nitrate-depleted beetroot juice. One
subject was excluded from these analyses due to lack of carotid flow
data during one of the study visits.
Pressure–flow analyses
Pressure and Doppler flow velocity files were processed off-line using
custom-designed software written in Matlab (The Mathworks, Natick,
MA, USA) as previously described.20 A representative example of
pressure–flow data processing is shown in Figures 1 and 2. Time align-
ment of pressure and LV outflow curves was performed to maximize:
(i) the rapid systolic upstroke of pressure and flow; (ii) concordance
© 2017 The Authors
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Figure 1 Example of pressure–flow analyses. Tonometric pressure data are shown at the top (left), along with the signal-averaged pressure
waveform (top right, red). Doppler flow interrogations were performed, as shown for the carotid (left) and left ventricular outflow (right)
locations. Tracing and signal averaging of flow waveforms (bottom blue curves) was subsequently performed. The carotid pressure waveform
is used for both carotid pressure–flow analyses and aortic pressure–flow analyses, since the carotid pressure is a good surrogate of the aortic
pressure waveform.
of the pressure dicrotic notch and cessation of flow in the LV outflow
tract, or the flow dicrotic notch in the carotid; (iii) linearity of the
early systolic pressure–flow relationship.
We computed aortic input impedance (Figure 2), which characterizes
the ratio of pulsatile pressure over flow in each harmonic of heart rate.
In this analysis, the fundamental frequency, or 1st harmonic, is the heart
rate, and higher harmonics are multiples of that frequency. Proximal
aortic characteristic impedance (Zc) was computed in the frequency
domain. Each pressure and flow harmonic was separated into forward
and backward components using wave separation analysis.21,22 We
assessed the reflection coefficient in the first three harmonics. These
are the relevant harmonics for assessing wave reflections because:
(i) they contain the vast majority of the pulsatile energy in pressure
and flow signals; (ii) at higher frequencies, reflections cancel out at
random, and the input impedance spectrum hovers around aortic root
characteristic impedance, mimicking a reflection-free system.
As the reflection coefficient is derived from the ratio of two sine
waves, it is a complex number with an amplitude and phase-angle,
which can correspond to different degrees of destructive or construc-
tive interference between forward and backward waves. Therefore,
the net effect of reflections was expressed as the real part of the
reflection coefficient, which becomes increasingly positive as pressure
from wave reflections increases (constructive interference), and ..
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. negative when destructive interference leads to a net decrease in
pressure by wave reflections at a given harmonic.23
We also reconstructed the forward and backward pressure waves in
the time domain. The sum of forward and backward pressure harmon-
ics yields the forward and backward waves, respectively (Figure 2). The
time of onset of the reflected wave was defined as the time at which
the reflected wave starts adding to mean pressure. We computed the
Buckberg index (also known as the sub-endocardial viability ratio), as
the ratio of diastolic/systolic pressure–time integrals (i.e. areas under
the pressure curve). This index provides an assessment of the effect of
pulsatile haemodynamics on myocardial oxygen demand (systolic load)
vs. supply (perfusion pressure).24
We also performed analyses of carotid pressure–flow relations.
Haemodynamic analysis commonly assumes a parabolic or flat flow
velocity profile to convert velocity measured in a sample volume into
a volumetric flow. However, this simplification may be inadequate for
the carotid artery, as the flow velocity profile is neither of both. We
therefore implemented a conversion accounting for the Womersley
number (a well-established dimensionless fluid-dynamics parameter for
oscillatory flow), as previously described.25
In our laboratory, repeated measurements of all indices from aortic
and carotid pressure–flow analyses yielded coefficients of variation of
17% or less.
© 2017 The Authors
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Figure 2 Carotid (left panels) and aortic (right panels) pressure–flow pairs are processed via mathematical analyses in the frequency domain.
The input impedance spectrum, which consists of modulus (red) and phase (blue) is obtained. Characteristic impedance (Zc, dashed line in
modulus plot) is computed based on the average modulus of higher harmonics of input impedance modulus. Zc is a local vascular property of
the aortic root or carotid artery, which governs the local pressure–flow relation in the absence of wave reflections. Once Zc is known, the
modulus and phase of the reflection coefficient in the frequency domain (at each harmonic) can be computed (not shown), along with the net
contribution of reflections to pressure at each harmonic (i.e. the real part of the reflection coefficient). Reflection coefficients in the frequency
domain are derived purely from the input impedance spectrum and thus depend purely on arterial load. The first three harmonics contain the
vast majority of the pulsatile energy and are the relevant harmonics. We also performed wave separation in the time domain, as shown in the
bottom panels. This approach yields forward (green dashed line) and backward (red dotted line) waves reconstructed in the time domain. At
the aorta, forward and backward wave amplitude and morphology in the time domain are not purely dependent on arterial load, but depend
also on re-reflections in the heart and the left ventricular contraction pattern.
Statistical analysis
Descriptive data are presented as mean± standard deviation for con-
tinuous variables, or counts (%) for categorical variables. Comparisons
between pre- and post-NTG values for sub-study 1, and between val-
ues corresponding to nitrate-rich vs. nitrate-depleted beetroot juice
administration for sub-study 2, were performed using paired Student’s
t-test. Physiologic indices were expressed as absolute values at each
time point, as well as absolute differences between measurements
(with 95% confidence intervals). A two-tailed P value of <0.05 was
considered statistically significant. Statistical analyses were performed
using SPSS version 15 for Mac-OS (SPSS Inc., Chicago, IL, USA).
Results
General characteristics of the study populations for sub-studies 1
and 2 are shown in Table 1. The characteristics of study subjects
in both sub-studies were very similar. In both sub-studies, subjects ..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
.. were obese, with a high prevalence of hypertension and diabetes,
as well as left atrial enlargement and a high mitral E/e’ ratio. Both
study samples were composed predominantly of males, with a high
proportion of African-Americans. All subjects in both sub-studies
had New York Heart Association class II–III symptoms.
Sub-study 1: effects of sublingual
nitroglycerin on aortic and carotid
haemodynamics
Key haemodynamic parameters measured before and after the
administration of NTG are shown in Table 2 and Figure 3. Nitro-
glycerin reduced central systolic and mean pressure. Nitroglycerin
did not have any significant effect on the amplitude of forward or
backward waves, the ratio of backward/forwards wave amplitudes,
or the time to reflected wave onset. Nitroglycerin tended to delay
the peak of the reflected wave, but did not improve the Buckberg
© 2017 The Authors
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Table 1 General characteristics of study subjects
Variable NTG sub-study
(sub-study 1) (n= 26)
Beetroot study
(sub-study 2) (n=16)
P-value
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Age, years [median (IQR)] 60 (56–65) 65 (62.5–70.5) 0.10
Male sex 20 (76.9) 14 (87.5) 0.68
Race 0.15
African-American 16 (61.5) 14 (87.5)
Caucasian 9 (34.6) 2 (12.5)
BMI, kg/m2 36.5 (6.5) 34.4 (3.5) 0.24
Obesity (BMI >30 kg/m2) 22 (84.6) 15 (93.8) 0.63
Current smoker 4 (15.4) 1 (6.3) 0.63
Hypertension 24 (92.3) 16 (100) 0.52
Diabetes 17 (65.4) 11 (68.8) 0.82
Coronary artery disease 8 (30.8) 3 (18.8) 0.49
Chronic kidney disease (eGFR <60mL/min/1.73m2) 9 (34.6) 5 (31.3) 0.82
Drug therapy
Beta-blocker 14 (53.9) 10 (62.5) 0.58
ACE-inhibitor/ARB 18 (69.2) 10 (62.5) 0.65
Calcium-channel blocker 14 (53.9) 7 (43.8) 0.53
Mineralocorticoid receptor antagonist 0 (0) 1 (6.3) 0.38
Statin 15 (57.7) 9 (56.3) 0.93
Aspirin 17 (65.4) 14 (87.5) 0.16
Thiazide 14 (53.9) 4 (25.0) 0.07
Loop diuretic 13 (50.0) 6 (37.5) 0.43
Laboratory data
eGFR*, mL/min/1.73m2 [median (IQR)] 74.1 (53.5–95.4) 65.5 (52.4–89.5) 0.95
Echocardiography
LV ejection fraction, % [median (IQR)] 57.4 (55.0–65.5) 62.4 (57.5–69.8) 0.30
Left atrial volume index, mL/m2 30.3 (10.9) 35.7 (10.9) 0.13
Mitral E-wave velocity, cm/s 81.8 (24.9) 71.7 (16.4) 0.16
Mitral A-wave velocity, cm/s 79.2 (24.6) 73.3 (24.2) 0.45
Mitral septal tissue Doppler velocity, cm/s 6.6 (2.2) 6.5 (1.7) 0.88
Mitral E/e’ ratio [median (IQR)] 12.8 (11.0–14.4) 11.4 (9.2–13.3) 0.17
TAPSE, cm [median (IQR)] 2.3 (2.1–2.6) 2.6 (2.1–2.8) 0.44
TAPSE <1.6 cm 0 (0) 0 (0)
Tricuspid regurgitant jet peak gradient†, mmHg 31.8 (3.7) 27.9 (8.9) 0.054
LV end-diastolic diameter, cm 4.8 (0.6) 4.5 (0.6) 0.12
LV mass, g [median (IQR)] 243.7 (214.1–318.3) 236.6 (183.2–275.2) 0.62
LV mass indexed to height, g/m1.7 [median (IQR)] 96.9 (71.7–114.1) 91.6 (70.7–102.8) 0.39
LV mass indexed to BSA, g/m2 109 (23.5) 106.3 (37.6) 0.77
Relative wall thickness, cm [median (IQR)] 0.52 (0.47–0.58) 0.59 (0.54–0.66) 0.041
NT-proBNP, pg/mL [median (IQR)] 250.5 (90.5–510.6) 148.0 (61.7–272.5) 0.16
Ejection duration, ms 318 (28) 330 (35) 0.22
Values are expressed and mean± standard deviation, or number (%), unless otherwise specified.
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; BSA, body surface area; eGFR, estimated glomerular filtration rate; IQR,
interquartile range; LV, left ventricular; NT-proBNP, N-terminal pro-brain natriuretic peptide; TAPSE, tricuspid annular plane systolic excursion.
*eGFR was calculated using the Modification of Diet in Renal Disease equation.
†Could be assessed reliably from the tricuspid regurgitation envelope in only nine subjects in sub-study 1 and in seven subjects in sub-study 2.
index. Nitroglycerin did not significantly reduce aortic root char-
acteristic impedance.
Table 2 and Figure 3 show the effect of NTG on the real part of
the reflection coefficient in the first three harmonics. Nitroglycerin
reduced the reflection coefficient of the 1st harmonic, but did not
reduce it in the 2nd harmonic and actually tended to increase the
reflection coefficient of the 3rd harmonic.
Despite these inconsistent effects on systemic wave reflections,
NTG markedly reduced carotid artery Zc, increased carotid
cross-sectional area and reduced carotid bed vascular resistance. ..
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. Effects of inorganic nitrate on aortic
and carotid haemodynamics
Key comparisons of haemodynamic parameters obtained after
administration of nitrate-rich beetroot juice vs. placebo juice
are shown in Table 3 and Figure 3. Inorganic nitrate did not
significantly reduce central systolic or mean pressure. Similar to
NTG, inorganic nitrate did not have any significant effect on
the amplitude of forward or backward waves or the ratio of
backward/forwards wave amplitudes, and did not reduce aortic
© 2017 The Authors
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Table 2 Aortic and carotid pulsatile haemodynamics before (pre) and after (post) administration of sublingual
nitroglycerin (NTG)
Variable Pre-NTG Post-NTG P-value
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Central systolic blood pressure, mmHg 133.6 (27.6) 120.5 (29.8) 0.011
Central pulse pressure, mmHg 59.5 (23.6) 50 (19.4) 0.06
Central mean arterial pressure, mmHg 96.8 (17) 90.5 (20.4) 0.019
Central diastolic blood pressure, mmHg 74 (15.4) 70.5 (15.3) 0.18
Aortic pressure–flow relations
Aortic characteristic impedance, dynes ⋅ s/cm5 172 (69) 174 (119) 0.93
Reflection coefficient, 1st harmonic 0.093 (26) 0.002 (26) 0.017
Reflection coefficient, 2nd harmonic −0.071 (26) −0.117 (26) 0.16
Reflection coefficient, 3rd harmonic −0.012 (26) 0.058 (26) 0.054
Forward wave amplitude, mmHg* 52.6 (20.2) 47.6 (16.6) 0.26
Backward wave amplitude, mmHg* 19.1 (9.1) 16.9 (7.5) 0.21
Backward/forward wave amplitude* 0.36 (0.07) 0.35 (0.08) 0.33
Time to reflected wave onset, ms 78 (30) 89 (44) 0.22
Buckberg index, % 130 (33) 129 (33) 0.81
Carotid pressure–flow relations
Carotid characteristic impedance, dynes ⋅ s/cm5 3440 (2757) 1923 (1277) 0.002
Carotid cross-sectional area, cm2 0.38 (0.09) 0.43 (0.1) <0.0001
Carotid bed vascular resistance, dynes ⋅ s/cm5 19 580 (13 402) 13 078 (8974) 0.001
*Computed in the time domain.
Figure 3 Changes in key pulsatile haemodynamic indices in the aorta (right) and the carotid artery (left), in sub-study 1 [sublingual nitroglycerin
(NTG), solid blue bars] and sub-study 2 (inorganic nitrate, solid red bars). Mean changes± standard errors are shown.
© 2017 The Authors
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Table 3 Aortic and carotid pulsatile haemodynamics after administration of 12.9 mmoL of inorganic nitrate
(nitrate-rich beetroot juice, NO3) vs. placebo juice (nitrate-depleted beetroot juice)
Variable Placebo NO3 P-value. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Central systolic blood pressure, mmHg 130 (20.8) 126.6 (24.2) 0.50
Central pulse pressure, mmHg 55.3 (16.7) 51 (18) 0.34
Central diastolic blood pressure, mmHg 74.7 (12.6) 75.6 (9.8) 0.70
Central mean arterial pressure, mmHg 97.6 (14.8) 96.4 (15.2) 0.70
Aortic pressure–flow relations
Aortic characteristic impedance, dynes ⋅ s/cm5 163 (74) 185 (64) 0.20
Reflection coefficient, 1st harmonic 0.119 (0.15) −0.001 (0.21) 0.032
Reflection coefficient, 2nd harmonic −0.03 (0.13) −0.144 (0.15) 0.012
Reflection coefficient, 3rd harmonic 0.046 (0.16) −0.042 (0.16) 0.091
Forward wave amplitude, mmHg* 47.2 (13.8) 47.1 (14.1) 0.98
Backward wave amplitude, mmHg* 16.8 (6) 18.8 (7.9) 0.30
Backward/forward wave amplitude* 0.35 (0.05) 0.39 (0.08) 0.08
Time to reflected wave onset, ms 64 (30) 93 (30) 0.016
Buckberg index, % 128 (29) 141 (25) 0.053
Carotid pressure–flow relations
Carotid characteristic impedance, dynes ⋅ s/cm5 3013 (1867) 2928 (1279) 0.80
Carotid cross-sectional area, cm2 0.37 (0.08) 0.40 (0.12) 0.15
Carotid bed vascular resistance, dynes ⋅ s/cm5 19 391 (13 557) 16 624 (6800) 0.38
*Computed in the time domain.
root characteristic impedance. However, it significantly delayed
the systolic onset of the reflected wave, moved its peak well into
diastole, and tended to improve the Buckberg index.
Table 3 and Figure 3 show the effect of inorganic nitrate on the
real part of the reflection coefficient in harmonics 1–3. Inorganic
nitrate significantly reduced the reflection coefficient of the 1st and
2nd harmonics, and tended to reduce the reflection coefficient of
the 3rd harmonic. In contrast to NTG, inorganic nitrate did not
reduce reduced carotid artery Zc, carotid cross-sectional area, or
carotid bed vascular resistance.
Discussion
We assessed the effects of organic and inorganic nitrate on aor-
tic and carotid pulsatile haemodynamics in HFpEF. We demon-
strate that organic nitrate substantially reduced blood pressure,
but reduced arterial wave reflections inconsistently across the first
three harmonics of the pressure–flow relation (in which most of
the pulsatile energy is contained). Nitroglycerin did not significantly
improve the Buckberg index and produced profound vasodilatation
in the carotid territory, with a reduction in cerebrovascular resis-
tance and carotid characteristic impedance. In contrast, inorganic
nitrate produced consistent reductions in wave reflections across
the first three harmonics, with a delay in the reflected wave and
a trend for improvement in the Buckberg index, without signif-
icant cerebrovascular dilatation. These haemodynamic differences
likely underlie the differential clinical effects of organic vs. inorganic
nitrate observed in recent clinical trials.
While both organic and inorganic nitrate/nitrite ultimately
act by increasing NO bioavailability, biochemical differences
exist between the two classes of drugs that lead to important ..
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.. differences in their action. Inorganic nitrate is reduced to nitrite
and NO via the nitrate–nitrite–NO pathway,16,17 which involves
the reduction of nitrate to nitrite upon ingestion and when nitrate
is subsequently excreted by the salivary glands (enterosalivary
circulation).26 Subsequent reduction of nitrite to NO occurs via:
(i) a hypoxia/acidosis-dependent mechanism (which enhances
reductions in microvascular resistance during exercise),14 and (ii)
a ‘paradoxic’ normoxia-dependent mechanism operating in mus-
cular conduit arteries,18 which explains the effect on arterial wave
reflections.14,18 There also appears to be non-enzymatic nitrite
reduction to NO in the acid gastric medium.27 In contrast, organic
nitrates require activation in the cytochrome-P450 system, leading
to tonic NO release.28 Alternative activation via mitochondrial
aldehyde dehydrogenase for NTG and other organic nitrates also
occurs.28
Headache is a common side effect of organic nitrates, and can
limit compliance with these medications. Hypotension can be seen,
and may result in syncope.12,16 In contrast, inorganic nitrate has
been well tolerated in HFpEF, with no limiting side effects, as
reported in two recent trials.14,15 No significant hypotension and,
in particular, no vasoactive symptoms (such as headache) were
reported. These side effect differences are consistent with the
observed haemodynamic effects observed in our study. The pro-
found carotid bed vasodilatation seen in response to NTG, but
not inorganic nitrate, is likely due to differences in the activation
of these compounds. The high mitochondrial content of neurons
may facilitate the activation of NTG by mitochondrial aldehyde
dehydrogenase in the brain, thus reducing microvascular resis-
tance in the cerebrovascular bed. In contrast, inorganic nitrite
(produced via reduction in inorganic nitrate) is reduced to NO in
the microvasculature, but this conversion occurs preferentially in
© 2017 The Authors
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conditions of hypoxia/acidosis.16,17 Such conditions are not present
in the brain, a highly aerobic organ which demonstrates relatively
preserved microvascular oxygenation29 due to its low resistance
and high arterial flow. Therefore, conditions of hypoxia and acido-
sis are not present in the cerebral microvasculature, explaining the
lack of significant effects of inorganic nitrate in our study.
Wave reflections originate at sites of impedance mismatch
throughout the arterial tree and return to the heart during ejec-
tion, increasing pulsatile load and affecting the LV loading sequence
(early vs. late systolic load).22,30 Wave reflections and late systolic
load have been shown to cause diastolic dysfunction and myocar-
dial remodelling in animal models.1,2 Human studies demonstrated
a relationship between increased wave reflections/late systolic load
and worse longitudinal LV function,3 LV hypertrophy,4 and a higher
risk of incident new-onset HF5 and readmission after an episode of
established acute decompensated HF.6
In our study, both NTG and inorganic nitrate reduced wave
reflections. However, inorganic nitrate produced numerically
greater and more consistent reductions in the real part of the
reflection coefficient across the first three harmonics, which
contain most of the pulsatile energy. In contrast, NTG reduced
the real component of the reflection coefficient only in the
1st harmonic, without an effect in the 2nd harmonic, and an
increase in the 3rd harmonic. The real part of the reflection
coefficient characterizes the net effect of wave reflections on
the pressure–flow relation in the aorta at a given harmonic.23
Inorganic nitrate, but not NTG, delayed the reflected wave and
tended to improve the Buckberg index (which characterizes
the effect of pulsatile haemodynamics on LV systolic load vs.
diastolic perfusion pressure). The reduction in wave reflections
with inorganic nitrate occurred without reductions in systemic
vascular resistance or blood pressure. This clearly indicates that
the effects of inorganic nitrate on microvascular resistance/blood
pressure and those on wave reflections are not necessarily linked.
Reductions in wave reflections can thus be achieved in the absence
of significant hypotension. Although these haemodynamic effects
are unexpected from the well-known hypoxia-mediated reduction
of nitrite in the microvasculature, they are consistent with the
recently described paradoxic normoxia-dependent activation of
inorganic nitrite in the wall of muscular conduit arteries,18 because
muscular arteries are known to modify the magnitude and phase
of wave reflections returning to the proximal aorta.22,24
The effects of inorganic nitrate on pulsatile load from wave
reflections demonstrated in our study, along with the absence
of cerebrovascular effects and side effects, is helpful not
only to interpret its demonstrated short-term clinical effects
(i.e. improvements in exercise tolerance and the absence of side
effects such as headache), but may also have implications for its
long-term clinical effects. By virtue of reducing wave reflections,
which are deleterious for the left ventricle, inorganic nitrate may
exert long-term ‘disease-modifying’ effects in HFpEF, potentially
reducing LV diastolic dysfunction and remodelling. We are cur-
rently assessing the efficacy of sustained administration of inorganic
nitrate (oral potassium nitrate) in a randomized cross-over phase
IIb trial funded by the National Heart, Lung and Blood Institute
(KNO3CK OUT HFPEF trial; clinicaltrials.gov NCT02840799). A .
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. single-dose study with inorganic nitrite yielded promising results
in HFpEF,31 and a larger study with inhaled sodium nitrite (INDIE
HFPEF; clinicaltrials.gov NCT02742129) is ongoing.
An interesting observation is the absence of significant effects
of either NTG or inorganic nitrate on the ratio of amplitudes of
backward/forward waves, which is a commonly used index of wave
reflections. It should be noted that this ratio does not account for
the time-resolved shape of the waveforms (which can be different
despite identical amplitudes). Similarly, this ratio does not account
for the time at which the reflected wave exerts its effects on central
pressure (late systole vs. diastole). Furthermore, the amplitudes
of both forward and backward waves are not purely a function
of arterial properties, but are heavily dependent on ventricular
contraction dynamics. In addition, the ratio of backward/forward
waves is confounded by rectified reflections (i.e. re-reflections
in the heart), which substantially contribute to forward wave
amplitude.32 Despite the lack of change in reflection magnitude,
detailed analyses in the time domain demonstrated favourable
changes (delay in the onset of the reflected wave after ejection,
and a trend towards improvement in the Buckberg index) with
inorganic nitrate, but not with NTG.
Our study should be interpreted in the context of its strengths
and limitations. Strengths include the careful assessment of
pulsatile carotid and aortic haemodynamics using state-of-the-art
non-invasive pressure–flow analyses, rather than pressure-only
approaches. Input impedance assessments distinctly characterize
arterial properties distal to the point of measurement, whereas
pressure-only approaches (such as assessments of augmentation
index) can be confounded by changes in ventricular contraction
or preload. Additional strengths of our study include the use
of identical methods to measure haemodynamics after organic
and inorganic nitrate administration, facilitating the interpretation
of differential haemodynamic effects. Our study also has limita-
tions. Our study populations were relatively small; however, the
paired nature of the analyses reduced measurement variability and
enhanced detection of drug effects in each sub-study. Owing to
the characteristics of the patient population at the VA Medical
Center, where most subjects were enrolled, our study populations
were composed primarily of men. Our population was predomi-
nantly African-American. Larger studies will be required to assess
whether the haemodynamic effects of inorganic nitrate differ by
ethnicity. Enrollment in the ongoing KNO3CK OUT HFpEF trial is
stratified based on gender and ethnicity; this study is also assessing
detailed haemodynamic phenotypes and will clarify this issue. The
exclusion of patients with atrial fibrillation reduces generalizability
of the findings to the important subject of patients who have atrial
fibrillation in the setting of HFpEF. We performed two separate
sub-studies with different designs. We tested the effects of NTG
compared to the values before drug administration, whereas the
effects of inorganic nitrate were tested in a cross-over blinded
design. This was an acute administration study, and the chronic
effects of these drugs on the carotid and peripheral circulations
could be different. The patient population had relatively mild
HFpEF as evidenced by the relatively low use of loop diuretics;
therefore, these results may not apply to patients who have more
severe or advanced HFpEF.
© 2017 The Authors
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Conclusions
We compared the effects of organic and inorganic nitrate on aor-
tic and carotid pulsatile haemodynamics in patients with HFpEF.
We demonstrate that organic nitrate administration reduced arte-
rial wave reflections less consistently than observed with inorganic
nitrate. Organic nitrate also produced profound vasodilatation in
the carotid territory, with a reduction in cerebrovascular resistance
and carotid characteristic impedance, whereas inorganic nitrate did
not produce significant cerebrovascular dilatation. These impor-
tant haemodynamic differences are likely related to the differential
clinical effects of these agents documented in recent clinical trials.
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